Cancer Risk Assessment for the Proactive Individual
You already invest in your health. Now you can add early cancer risk assessment to your preventive care plan for peace of mind and more informed conversations with your physician.
Why It Matters
For many solid tumours, symptoms only appear once cancer is more advanced. Standard screening programs like mammograms or colonoscopies are important, but they are limited to certain age groups or risk categories, and only cover a small number of cancer types.
The miRoncol Real-time Multi-Cancer Early Risk Assessment helps fill this gap. By analyzing microRNA patterns linked to common solid tumours such as lung, colorectal, and prostate cancers, the test offers real-time molecular insight into your current cancer risk.
Why Health Conscious People Choose Early Cancer Risk Assessment
Peace of Mind
Add confidence and reassurance to your health routine.
Complements Other Screening
Works alongside MRI, genetic panels, and annual checkups.
Covers Multiple Cancers
Looks for signals associated with more than a dozen common solid tumour types.
Supports Physician Conversations
Provides meaningful insights that you can review with your doctor.
How It Fits Into a Preventive Lifestyle
- As part of your annual wellness assessment
- Alongside executive health programs or integrative medicine packages
- When you want more certainty about what’s happening in your body today for potential tumors
Your Next Step
The miRoncol test provides an early cancer risk assessment — a molecular-level snapshot that complements existing screening programs. Results are designed to support physician-led decision-making, not replace it.
